These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 6434551

  • 21. [Parkinson disease. The clinical picture and therapy].
    Huber M.
    Dtsch Med Wochenschr; 1988 Jun 16; 113(24):992-8. PubMed ID: 2897901
    [No Abstract] [Full Text] [Related]

  • 22. Parkinson's disease: new treatments.
    Stewart RM.
    Compr Ther; 1981 Apr 16; 7(4):38-44. PubMed ID: 7237986
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Parkinson's disease.
    Morley JB.
    Aust Fam Physician; 1977 Jan 16; 6(1):29-30, 32, 34-5. PubMed ID: 16582
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Secondary effects of prolonged levodopa therapy in Parkinson's disease].
    Peiró Grasa A, Grau-Veciana JM.
    Med Clin (Barc); 1985 Jun 15; 85(3):88-91. PubMed ID: 4021630
    [No Abstract] [Full Text] [Related]

  • 29. Anticholinergics and dyskinesia.
    Linazasoro G.
    Mov Disord; 1994 Nov 15; 9(6):689. PubMed ID: 7845412
    [No Abstract] [Full Text] [Related]

  • 30. An analysis of treatment options and outcome in patients with Parkinson's disease and severe dyskinesias.
    Mark MH, Sage JI.
    Ann Clin Lab Sci; 1994 Nov 15; 24(1):12-21. PubMed ID: 8147565
    [Abstract] [Full Text] [Related]

  • 31. Individualization of levodopa therapy.
    Bianchine JR, Sunyapridakul L.
    Med Clin North Am; 1974 Sep 15; 58(5):1071-81. PubMed ID: 4609364
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. In practice. Parkinson's disease.
    Hill JW.
    N Z Med J; 1979 Oct 10; 90(645):300-4. PubMed ID: 229444
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Further experiences with low doses of bromocriptine in Parkinson's disease.
    Fahn S, Côté LJ, Barrett RE, Snider SR.
    Adv Biochem Psychopharmacol; 1980 Oct 10; 23():255-60. PubMed ID: 7395615
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Amantadine-induced "vocal" myoclonus.
    Pfeiffer RF.
    Mov Disord; 1996 Jan 10; 11(1):104-6. PubMed ID: 8771080
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.